PLSE
Pulse Biosciences, Inc - Common Stock (PLSE)
$07
About Pulse Biosciences, Inc - Common Stock (PLSE)
Pulse Biosciences, Inc. operates as an immuno-oncology company developing a proprietary oncolytic electroceutical therapy based on its Nano Pulse Stimulation (NPS) technology. It manufactures surgical and medical instruments using a novel and proprietary platform technology called Nano-Pulse Electro-Signaling. The NPES provides local tumor control and initiates an adaptive immune response with a vaccine-like effect by inducing immunogenic apoptosis of the cells. The company was founded on May 19, 2014 and is headquartered in Miami, FL.
Details
Daily high
$57.72
Daily low
$50.74
Price at open
$56.01
52 Week High
$58.90
52 Week Low
$12.56
Market cap
4.1B
Dividend yield
-
Volume
534,426
Avg. volume
376,304
P/E ratio
-48.59
Pulse Biosciences, Inc - Common Stock News
Details
Daily high
$57.72
Daily low
$50.74
Price at open
$56.01
52 Week High
$58.90
52 Week Low
$12.56
Market cap
4.1B
Dividend yield
-
Volume
534,426
Avg. volume
376,304
P/E ratio
-48.59